News by date

Powered by mod LCA

NEWS

Viva Biotech and HQL Pharmaceuticals Join Forces to Form Powerhouse for Structure - and Fragment - Based Drug Discovery

Wednesday, 05 March 2014 00:00

Viva Biotech and HQL Pharmaceuticals Join Forces to Form Powerhouse for Structure - and Fragment - Based Drug Discovery

Viva Biotech Ltd., a leading company in structure-based and fragment based drug discovery services, based in Shanghai, China, and HQL Pharmaceuticals Ltd., a drug discovery company utilizing its super-power proprietary ChemSpace Scanner (CSS™) computational technology, based in Rehovot, Israel, today announced that they have entered into a strategic alliance to jointly provide a fully-integrated drug discovery services, focused on leads generation based on fragment screening.

[read the article]


GalChimia signs deal with HQL Pharmaceuticals

Monday, 19 September 2011 00:00

GalChimia, a Spanish provider of synthetic organic chemistry services is to work with HQL Pharmaceuticals for cancer research.

The Santiago de Compostela-based firm said it would work with the Israeli drug discovery firm to develop small molecules that cause programmed cell death by inhibiting protein-protein interactions targeting apoptotic pathways, which is said to play a key role in oncology.

read the whole news at Manufacturing Chemist